|
|
Volumn 23, Issue 1, 2017, Pages 5-7
|
|
Living therapeutics: Scientists genetically modify bacteria to deliver drugs
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
INSULIN;
INTERLEUKIN 10;
MESOTHELIN;
PROBIOTIC AGENT;
TREFOIL FACTOR;
YOGHURT;
ARTICLE;
COMMENSAL;
DRUG DELIVERY SYSTEM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOTHERAPY;
INFLAMMATORY BOWEL DISEASE;
LACTOBACILLUS;
LACTOBACILLUS JENSENII;
LISTERIA MONOCYTOGENES;
NONHUMAN;
PATHOGENICITY;
PRIORITY JOURNAL;
SCIENTIST;
TRANSGENIC ORGANISM;
ANIMAL;
BACTERIUM;
BIOTECHNOLOGY;
CLINICAL TRIAL (TOPIC);
ESCHERICHIA COLI;
FEMALE;
GENE THERAPY;
GENETICS;
LACTOCOCCUS LACTIS;
MALE;
MEDICINAL CHEMISTRY;
PHYSIOLOGY;
PROCEDURES;
TRENDS;
UNITED STATES;
ANIMALS;
BACTERIA;
BIOTECHNOLOGY;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS AS TOPIC;
ESCHERICHIA COLI;
FEMALE;
GENETIC THERAPY;
HIV INFECTIONS;
HUMANS;
IMMUNOTHERAPY;
LACTOCOCCUS LACTIS;
MALE;
PROBIOTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 85015294152
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0117-5 Document Type: Article |
|
Times cited : (31)
|
|
References (7)
|
